Silencing of GCS and Gb3 synthase, and inhibition of β-catenin recruitment decreased the expression of FGF-2 and Oct- 4, which are essential factors for stem cells, and significantly reduced the cancer pluripotency of iBCSCs [2]. This evidence concerns the gene UGCG and cancer.